PCRX vs XERS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 10, 2026
PCRX
XERS
Investment Advisor Scores
XERS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PCRX | XERS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 6.6934 | 36.3636 | PCRX |
| PEG Ratio | 11.2121 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 6.2% | 28.7% | XERS |
| Earnings Growth | -30.0% | 0.0% | XERS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 43.3/100 | 50.0/100 | XERS |
| Profit Margin | 2.0% | -5.1% | PCRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PCRX
NeutralMixed signals - no dominant trend phase, RSI 49
XERS
NeutralMixed signals - no dominant trend phase, RSI 30
Fundamentals Snapshot
| Metric | PCRX | XERS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.4 | 19.1 |
| Trailing P/E | 74.0 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.3% |
| Gross Margin | 0.8% | 0.9% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 0.34 | -0.10 |
| Dividend Yield | — | — |